Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis.
about
Early inflammatory markers in elicitation of allergic contact dermatitisDrug induced exfoliative dermatitis: state of the artHydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization, and in vitro drug release study.Redox control of asthma: molecular mechanisms and therapeutic opportunities.Much atopy about the skin: genome-wide molecular analysis of atopic eczema.Immunomodulatory action of intravenous immunoglobulin.Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity.An essential role for TAK1 in the contact hypersensitivity responseIVIG--mechanisms of action.Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany.Ufasomes Mediated Cutaneous Delivery of Dexamethasone: Formulation and Evaluation of Anti-Inflammatory Activity by Carrageenin-Induced Rat Paw Edema ModelGenes of tolerance.Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome).The mode of topical immunomodulators in the immunological network of atopic dermatitis.Toxic epidermal necrolysis: current evidence, practical management and future directions.Clinical uses of intravenous immunoglobulin.Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.Treatment strategies in toxic epidermal necrolysis syndrome: where are we at?Effector and regulatory mechanisms in allergic contact dermatitis.Health effects of probiotics on the skin.Contribution of CD4(+ )and CD8(+) T-cells in contact hypersensitivity and allergic contact dermatitis.Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus.Rotundarpene prevents TRAIL-induced apoptosis in human keratinocytes by suppressing the caspase-8- and Bid-pathways and the mitochondrial pathway.Resveratrol ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis-like lesions through effects on the epithelium.Effect of Bifidobacterium infantis on Interferon- gamma- induced keratinocyte apoptosis: a potential therapeutic approach to skin immune abnormalities.The immunophilin-ligands FK506 and V-10,367 mediate neuroprotection by the heat shock response.Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalentTacrolimus ointment in the management of atopic dermatitis.Apoptosis and loss of adhesion of bronchial epithelial cells in asthma.Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study.3,4,5-Tricaffeoylquinic Acid Attenuates TRAIL-induced Apoptosis in Human Keratinocytes by Suppressing Apoptosis-related Protein Activation.The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis.The role of T-cell reactivity towards the autoantigen α-NAC in atopic dermatitis.[How does eczema arise?].Topical application of rapamycin ointment ameliorates Dermatophagoides farina body extract-induced atopic dermatitis in NC/Nga mice.Salvia plebeia suppresses atopic dermatitis-like skin lesions.Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus ReportIn vitro and in vivo evidences for innate immune stimulators lactic acid bacterial starters isolated from fermented camel dairy products
P2860
Q24531952-B6975160-0235-46ED-803D-FD3FF0AFF217Q26739886-2548761B-AE88-44A6-9B23-3FC068203BF4Q33349360-DE1CEC75-9EFF-4453-8C1A-CD666C35339CQ33668491-04BC816E-D711-47F2-B5E3-90DECF122FCDQ34428151-B65544BC-0654-4651-9969-E9C0B3DACE03Q35013334-BA85C7A2-0BF4-43E9-9040-E16DBDB5CE95Q35083711-80420A2D-D1E7-4792-A3F6-E969FB0ABB6BQ35085718-DD78041F-E556-481D-AE57-072F3726FC2CQ35161081-5BED7B11-7254-49A1-B40E-6B95D9594E6DQ35748722-A2B94950-63D9-4299-85B1-6BCBB1B9824DQ35837675-90863847-959A-4D8A-9423-91F4FC81A5C7Q35855013-9EFA19B8-A3C9-4863-BDCA-9529FD56A8D2Q36043283-A6C0E78A-B172-4958-BEE0-27E06414A321Q36051518-83E3ED6A-1B1F-4F16-95C3-EBD094CB578BQ36222123-46A3A66E-B81F-4E67-9970-35FB82FD69A7Q36264883-246D51CD-F68B-41F4-AAFD-1500DC6DB471Q36515366-6D292007-E3AA-4AB0-B1FB-12C12E696DD0Q37053492-3089A3A1-BC28-4869-ABC6-52767D58C6C9Q37617470-64D2395B-85B0-4785-A861-DEF1BA6C55CDQ38173392-C06720FE-60BD-4862-8FAF-88AD5F74464AQ38474290-09B2C074-8FCB-4291-85B5-9FB716B7874BQ38702424-56D2A29A-E7B3-40CB-B690-C6980FA01A3BQ38951550-4BCA322F-DB60-4BFA-BE3F-B771FB242420Q39969104-385D0751-1089-49F3-BCE4-730EB6F2DF76Q40197121-D3BF7B6D-7E2D-41B9-BD4E-C5C7BB6EB6B2Q41835286-0B1C4B88-44EF-4ACD-ABB9-A6B430CAFCB4Q42010436-16D3909F-81F6-433A-817A-E3C4802DCB6DQ42081579-05572F17-C10A-4172-94F3-B9B9855DCBE0Q42484374-3CD19F96-6A9D-49B4-B424-34CEA318A7D1Q45120688-48005039-F826-41D0-9A81-E628B486BA3CQ46693050-FDB95EF5-2932-4DE0-BE93-F9CF4064BB85Q47564811-A1092257-4291-40D5-9C82-EF8E11E17460Q53293632-B6FEB956-EEE6-464E-A06B-EDFCD045363FQ53649407-B4EDBE8C-98DB-4B38-A055-4ADCACA5147BQ54346708-2E627A92-C67E-4AF9-BE63-E7BD1902DB63Q55073242-C8BFE6F4-203D-4BE0-BA3F-016C8A438C77Q57072093-0C56DA0C-41D3-44CE-94DC-080411967608Q57111381-D66795DE-DEA9-4977-B8B6-0B1872F2D836
P2860
Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Targeting keratinocyte apoptos ...... d allergic contact dermatitis.
@en
type
label
Targeting keratinocyte apoptos ...... d allergic contact dermatitis.
@en
prefLabel
Targeting keratinocyte apoptos ...... d allergic contact dermatitis.
@en
P2093
P356
P1476
Targeting keratinocyte apoptos ...... d allergic contact dermatitis.
@en
P2093
Bröcker EB
Schmid-Grendelmeier P
Trautmann A
P304
P356
10.1067/MAI.2001.118796
P407
P577
2001-11-01T00:00:00Z